Cowealth Medical China Co Ltd
SSE:603122
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cowealth Medical China Co Ltd
SSE:603122
|
CN |
Multiples-Based Value
The Multiples-Based Value for Cowealth Medical China Co Ltd (603122) under the Base Case is 4.55 CNY. Compared with the current market price of 16.57 CNY, the stock appears Overvalued by 73%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Cowealth Medical China Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
C
|
Cowealth Medical China Co Ltd
SSE:603122
|
6.6B CNY | 9.7 | -196.1 | -157.1 | -157.1 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
106.1B USD | 0.3 | 24.5 | 17.2 | 19.3 | |
| US |
|
Cencora Inc
NYSE:COR
|
62.2B USD | 0.2 | 38.3 | 13.6 | 17.2 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
62.2B USD | 0.2 | 38.3 | 13.5 | 17.1 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
50.7B USD | 0.2 | 30.5 | 14.7 | 19.1 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
31.2B AUD | 2.7 | 34.2 | 25.4 | 25.4 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.1B CNY | 0.2 | 11 | 8.6 | 8.6 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
61.4B CNY | 1.4 | 16.6 | 12.8 | 12.8 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.9B USD | 0.7 | 22.5 | 11 | 15.5 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
63.6B HKD | 0.1 | 7.9 | 0.7 | 0.8 |